NCT04066504 2026-03-18
NISSO
Sun Pharmaceutical Industries Limited
Completed
Clinical Trials
11 trialsNCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
NCT07068568 2025-07-16
BCC-Sonidegib
Federico II University
Completed
NCT05463757 2025-04-04
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Maastricht University Medical Center
Recruiting
NCT04679480 2024-07-30
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
University of Zurich
Phase 2 Active not recruiting
NCT00880308 2020-12-19
Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT01208831 2020-12-19
An East Asian Study of LDE225
Novartis
Phase 1 Completed
NCT01327053 2019-08-28
BOLT
Novartis
Phase 2 Completed
NCT02303041 2019-01-29
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Stanford University
Phase 2 Terminated
NCT01529450 2017-01-16
Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
Stanford University
Phase NA Completed
NCT01350115 2015-10-19
Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
Novartis
Phase 2 Completed